Pancreatic Cancer Research

ResearcherUniversitätsmedizin GreifswaldNo recent work listed

Lars Ivo Partecke

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5109292402. Sources: OpenAlex.

Their work

Papers
12 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
19
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: none · 2014: none · 2015: 2 papers · 2016: 2 papers · 2017: 3 papers · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper

Papers 12

  1. CCR4 Blockade Diminishes Intratumoral Macrophage Recruitment and Augments Survival of Syngeneic Pancreatic Cancer-Bearing Mice. Last author DOI 10.3390/biomedicines11061517↗
  2. Visceral Surgery Profoundly Affects the Cellular and Humoral Components of the Anti-Tumour Immune Response in a Murine Pancreatic Adenocarcinoma Model. Co-author DOI 10.3390/cancers14163850↗
  3. Cold Physical Plasma Selectively Elicits Apoptosis in Murine Pancreatic Cancer Cells In Vitro and In Ovo. Co-author DOI 10.21873/anticanres.12901↗
  4. Non-thermal plasma-treated solution demonstrates antitumor activity against pancreatic cancer cells in vitro and in vivo. Last author DOI 10.1038/s41598-017-08560-3↗
  5. LPS promotes resistance to TRAIL-induced apoptosis in pancreatic cancer. First author DOI 10.1186/s13027-017-0139-4↗
  6. Subdiaphragmatic vagotomy promotes tumor growth and reduces survival via TNFα in a murine pancreatic cancer model. Co-author DOI 10.18632/oncotarget.15019↗
  7. Chronic stress increases experimental pancreatic cancer growth, reduces survival and can be antagonised by beta-adrenergic receptor blockade. Co-author DOI 10.1016/j.pan.2016.03.005↗
  8. TRAIL Promotes Tumor Growth in a Syngeneic Murine Orthotopic Pancreatic Cancer Model and Affects the Host Immune Response. Co-author DOI 10.1097/mpa.0000000000000469↗
  9. Surgical trauma leads to a shorter survival in a murine orthotopic pancreatic cancer model. Last author DOI 10.1159/000368226↗
  10. Impact of diabetes type II and chronic inflammation on pancreatic cancer. Co-author DOI 10.1186/s12885-015-1047-x↗
  11. Tissue tolerable plasma (TTP) induces apoptosis in pancreatic cancer cells in vitro and in vivo. Co-author DOI 10.1186/1471-2407-12-473↗
  12. A syngeneic orthotopic murine model of pancreatic adenocarcinoma in the C57/BL6 mouse using the Panc02 and 6606PDA cell lines. Co-author DOI 10.1159/000329413↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wolfram von Bernstorff · 9 shared papers, 2011–2023 · strength 0.59
  2. Sander Bekeschus · 3 shared papers, 2017–2023 · strength 0.33
  3. Pia Menges · 3 shared papers, 2015–2022 · strength 0.30
  4. Frank Ulrich Weiß · 6 shared papers, 2011–2017 · strength 0.28
  5. André Käding · 5 shared papers, 2011–2017 · strength 0.27
  6. Katharina Beyer · 4 shared papers, 2016–2017 · strength 0.25
  7. Friederike Loening · 1 shared paper, 2022 · strength 0.20
  8. Maik Lenz · 1 shared paper, 2023 · strength 0.17
  9. Lea Miebach · 1 shared paper, 2023 · strength 0.17
  10. Stephan Kersting · 1 shared paper, 2023 · strength 0.17
  11. Aydar Khabipov · 1 shared paper, 2023 · strength 0.17
  12. Kim Rouven Liedtke · 2 shared papers, 2017–2018 · strength 0.16
  13. Julia V. Mayerle · 3 shared papers, 2011–2017 · strength 0.13
  14. Wolfram Keßler · 2 shared papers, 2016–2017 · strength 0.11
  15. Markus M. Lerch · 2 shared papers, 2011–2016 · strength 0.07
  16. Dietmar Zechner · 1 shared paper, 2015 · strength 0.06
  17. Brigitte Vollmar · 1 shared paper, 2015 · strength 0.06
  18. Florian Bürtin · 1 shared paper, 2015 · strength 0.06
  19. A. Stier · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.